Hypoglycemia
📧 Sign up to get email alerts when something new happens for Hypoglycemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Counterregulation [NA]
A clinical trial investigating whether glial acetate metabolism can serve as a biomarker for hypoglycemic counterregulation in individuals w…
-
FDA approval · 2025-07-22FDA Approved: GLUCAGON — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic glucagon injection under an Original Application (ANDA214457). The approval enables Lupin to mar…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D [Phase 3]
A Phase 3 study evaluating the safety, efficacy, and pharmacodynamics of dasiglucagon as a hypoglycemia rescue therapy in children under 6 y…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes [NA]
An ongoing Indiana University clinical trial aims to enhance shared decision-making to guide care for people with diabetes and dementia/Alzh…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Pilot Feasibility Study for HypoPals, a Mobile Health Program for Improving Hypoglycemia Management. [NA]
Completed pilot feasibility study of HypoPals, a mobile health program to improve hypoglycemia management in Type 1 diabetes mellitus; resul…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Effects of a Hypoglycemia Protocol With Glucose Gel on Neonatal Intensive Care Unit (NICU) Admission
A Pediatrix-sponsored clinical trial evaluating a glucose gel–based hypoglycemia protocol to impact NICU admission has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Concordance of Hypoglycemia Measurement With Simultaneous Use of Two Devices for Continuous Glucose Measurement. [NA]
The clinical trial NCT06246578 evaluating concordance of hypoglycemia measurements using two continuous glucose monitoring devices in Type 1…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: DailyDose Smart Snack Study for T1D on MDI [NA]
Clinical trial update indicating the DailyDose Smart Snack Study in people with Type 1 Diabetes on multiple daily injections has completed a…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Safer Aging With Diabetes Monitoring [NA]
Clinical trial update indicates the 'Safer Aging With Diabetes Monitoring' study is recruiting, sponsored by Kaiser Permanente, focusing on …
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: DiGESTnewborn Study
The DiGESTnewborn clinical trial update shows the study at Cambridge University Hospitals NHS Foundation Trust is currently recruiting for g…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Continuous Glucose Monitoring for Hyperglycemia in Critically Ill Patients [NA]
Clinical trial update reporting completed results for continuous glucose monitoring to manage hyperglycemia and hypoglycemia in critically i…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Continuous Bloodsugar Monitoring System With a Sensor Compared to Fingerstick Bloodsugar Monitoring [NA]
This clinical trial registry entry describes a study evaluating a continuous glucose monitoring sensor versus fingerstick glucose monitoring…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Reducing Treatment Risk in Older Adults With Diabetes [NA]
A completed Kaiser Permanente trial evaluated strategies to reduce treatment risk, including hypoglycemia, in older adults with insulin-trea…
-
FDA approval · 2025-03-17FDA Approved: BAQSIMI — Supplemental Application (Amphastar Pharmaceuticals, Inc.)
The FDA approved a supplemental application for BAQSIMI (glucagon) from Amphastar Pharmaceuticals, Inc., the nasal glucagon product for emer…
-
FDA approval · 2025-03-14FDA Approved: GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR — Supplemental Application (Xeris Pharmaceuticals, Inc.)
FDA approved a supplemental application to add the GVOKE HYPOPEN 0.5 mg auto-injector as a new administration form for glucagon injection so…
-
CLINICAL_TRIALS withdrawal · 2025-03-14Clinical Trial Update: An Exploratory Study of 68Ga-DOTA-SEMA in Preoperative Precise Imaging of Patients with Glucagon-Like Peptide-1 Receptor (GLP1R) Positive Insulinomas [NA]
This clinical trial update shows that the NCT06759740 study evaluating 68Ga-DOTA-SEMA for preoperative imaging of GLP1R-positive insulinomas…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Evaluation of the Ambuja Cement Foundation Noncommunicable Disease Program in Bathinda District of Punjab, India [NA]
Completed evaluation of the Ambuja Cement Foundation Noncommunicable Disease program in Bathinda district, Punjab, assessing outcomes relate…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Adrenergic System in Islet Transplantation [EARLY_Phase 1]
A Phase 1 clinical trial update exploring the adrenergic system in islet transplantation for type 1 diabetes and related hypoglycemia condit…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: The Effectiveness of Multimedia Education on Hypoglycemic Management. [NA]
The trial evaluated the effectiveness of multimedia education for managing hypoglycemia in people with type 2 diabetes. Results have been po…
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Hypoglycemia Prevention and Awareness Program [NA]
The document provides a status update for a clinical trial focused on hypoglycemia prevention and awareness in people with diabetes. The tri…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes [NA]
A longitudinal study investigating glucagon response to hypoglycemia in children and adolescents with new-onset Type 1 diabetes; currently r…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Dextrose Gel Does Not Prevent Neonatal Hypoglycemia [Phase 2, Phase 3]
Phase 2/3 trial evaluating dextrose gel to prevent neonatal hypoglycemia did not prevent the condition.
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Prehospital Provider Training With Augmented Reality (AR) [NA]
A clinical trial evaluating prehospital provider training with augmented reality has completed. The provided snippet does not include effica…
-
FDA approval · 2024-12-12FDA Approved: GLUCAGON — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved Mylan's original application for a generic glucagon injectable product.
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: The Effect of Glucose-dependent Insulinotropic Polypeptide on the Alpha Cell Response to Hypoglycaemia in Patients with Type 1 Diabetes [NA]
The trial evaluated whether glucose-dependent insulinotropic polypeptide (GIP) modulates alpha cell response to hypoglycemia in people with …